Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuning Xu

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Drug Delivery|January 12, 2020
Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistanceDanyang Li, Ruixue Cui, Shuning Xu, et al.
BMC Ophthalmology|January 16, 2026
Lipid-rich vitreous hemorrhage associated with lipemia retinalis in a young patient with proliferative diabetic retinopathyShuning Xu, Xue Zhang, Bo Jiang, et al.
Pathology Oncology Research : POR|October 31, 2018
PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell CarcinomaKe Li, Ying Liu, Shuning Xu, et al.
Frontiers in Plant Science|March 3, 2023
Research of intelligent reasoning system of <i>Arabidopsis thaliana</i> phenotype based on automated multi-task machine learningPeisen Yuan, Shuning Xu, Zhaoyu Zhai, et al.
Frontiers in Oncology|September 5, 2022
Efficacy and safety of anlotinib plus programmed death-1 blockade versus anlotinib monotherapy as second or further-line treatment in advanced esophageal squamous cell carcinoma: A retrospective studyYing Liu, Qingqing Ge, Shuning Xu, et al.
Journal of Colloid and Interface Science|July 10, 2025
Targeted multifunctional nano-engineered carbon dots with enhanced synergistic photothermal/photodynamic performance for precision tumor therapyHongliang Wang, Tian Tian, Shuning Xu, et al.
Medicine|June 25, 2019
MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case reportDanyang Li, Shuning Xu, Miaomiao Sun, et al.
Frontiers in Immunology|March 11, 2026
NOTCH3 attenuates cytotoxicity via RBPJ-dependent PVR upregulation to influence immunotherapy outcomes in colorectal cancerQi Ma, Shuning Xu, Ning Ma, et al.
Cancer Chemotherapy and Pharmacology|January 21, 2015
Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancerYing Liu, Zhonghai Ren, Shuning Xu, et al.
European Radiology|February 12, 2024
Spectral CT vs. diffusion-weighted imaging for the quantitative prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancerJing Li, Shuning Xu, Yi Wang, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Drug Delivery|January 12, 2020
Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistanceDanyang Li, Ruixue Cui, Shuning Xu, et al.
BMC Ophthalmology|January 16, 2026
Lipid-rich vitreous hemorrhage associated with lipemia retinalis in a young patient with proliferative diabetic retinopathyShuning Xu, Xue Zhang, Bo Jiang, et al.
Pathology Oncology Research : POR|October 31, 2018
PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell CarcinomaKe Li, Ying Liu, Shuning Xu, et al.
Frontiers in Plant Science|March 3, 2023
Research of intelligent reasoning system of <i>Arabidopsis thaliana</i> phenotype based on automated multi-task machine learningPeisen Yuan, Shuning Xu, Zhaoyu Zhai, et al.
Frontiers in Oncology|September 5, 2022
Efficacy and safety of anlotinib plus programmed death-1 blockade versus anlotinib monotherapy as second or further-line treatment in advanced esophageal squamous cell carcinoma: A retrospective studyYing Liu, Qingqing Ge, Shuning Xu, et al.
Journal of Colloid and Interface Science|July 10, 2025
Targeted multifunctional nano-engineered carbon dots with enhanced synergistic photothermal/photodynamic performance for precision tumor therapyHongliang Wang, Tian Tian, Shuning Xu, et al.
Medicine|June 25, 2019
MAID chemotherapy regimen as a treatment strategy for metastatic malignant ameloblastoma: A case reportDanyang Li, Shuning Xu, Miaomiao Sun, et al.
Frontiers in Immunology|March 11, 2026
NOTCH3 attenuates cytotoxicity via RBPJ-dependent PVR upregulation to influence immunotherapy outcomes in colorectal cancerQi Ma, Shuning Xu, Ning Ma, et al.
Cancer Chemotherapy and Pharmacology|January 21, 2015
Low-dose-intensity bevacizumab with weekly irinotecan for platinum- and taxanes-resistant epithelial ovarian cancerYing Liu, Zhonghai Ren, Shuning Xu, et al.
European Radiology|February 12, 2024
Spectral CT vs. diffusion-weighted imaging for the quantitative prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancerJing Li, Shuning Xu, Yi Wang, et al.
Pageof 4